Michael Schmertzler, Director at PTC THERAPEUTICS, INC. (PTCT), sold 1,500 shares at $27.81 ($42K) on 2024-01-08, disclosed to the SEC on 2024-01-10.
Scheduled sale ($42k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PTCT | SELL | 2026-08-28 | $1.8M | — | Filing → |
| PTCT | SELL | 2026-08-21 | $1.8M | — | Filing → |
| PTCT | SELL | 2023-06-09 | $45K | — | Filing → |